TSXV:CLAS.H - Post by User
Comment by
MiSdyngNASTYon May 25, 2020 9:20am
65 Views
Post# 31068137
RE:RE:RE:Kalytera Defaults on GVHD Program
RE:RE:RE:Kalytera Defaults on GVHD ProgramRead it bud. Kalytera acquired its GVHD program through the acquisition of Talent Biotechs Ltd. (Talent) in 2017. Kalyteras subsidiary, Kalytera Therapeutics Israel Ltd. (Kalytera Israel) owns the assets of the GVHD program, and is in default under a Promissory Note evidencing a USD $3 million debt that is owed by Kalytera Israel to the former shareholders of Talent